Gravas, Stavros
Malde, Sachin
Cornu, Jean-Nicolas
Gacci, Mauro
Gratzke, Christian
Herrmann, Thomas R. W.
Karavitakis, Markos
Mamoulakis, Charalampos http://orcid.org/0000-0002-8662-1275
Rieken, Malte
Sakalis, Vasileios I. http://orcid.org/0000-0003-0132-224X
Schouten, Natasha http://orcid.org/0000-0002-1918-2073
Smith, Emma J.
Speakman, Mark J.
Tikkinen, Kari A. O.
Alivizatos, Gerasimos
Bach, Thorsten
Bachmann, Alexander
Descazeaud, Aurelian
Desgrandchamps, François
Drake, Marcus
Emberton, Mark http://orcid.org/0000-0003-4230-0338
Kyriazis, Iason
Madersbacher, Stephan
Michel, Martin C.
N’Dow, James
Perachino, Massimo
Plass, Karin
Rioja Sanz, Carlos
Umbach, Roland
de Wildt, Michel
Oelke, Matthias
de la Rosette, Jean J. M. C. H. http://orcid.org/0000-0002-6308-1763
Article History
Received: 15 April 2023
Revised: 7 May 2023
Accepted: 13 July 2023
First Online: 24 July 2023
Competing interests
: ME: receives research support from the United Kingdom’s National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre and was appointed NIHR Senior Investigator in 2015. MO: consultant, speaker and/or trial participant for Apogepha, Astellas, Eli-Lilly, Ferring, GlaxoSmithKline, Pfizer, Pierre-Fabre, SAJA, Schwabe and SUN. MCM: consultancy and/or lecturer honoraria from Dr. Wilmar Schwabe, GSK, Stiftung Männergesundheit, Apogepha and Astellas. SG is a company consultant for Astellas and GSK; has received speaker honoraria from Astellas, Pierre Fabre and Ferring and has paid for access to the results of an independent study. J-NL Cornu is a Company consultant for Boston Scientific, Astellas, Medtronic, Mundipharma, STIMULI Technology (French); has received speaker honorarium from Astellas, Pierre Fabre Medicament, Recordati, Pfizer, Medtronic, Boston Scientific; has participated in clinical trials by Astellas, Coloplast, Allergan, IPSEN, Medtronic, IXALTIS, COUSIN Biotech, GT Urological; received fellowship and travel grants from Pierre Fabre Medicament, Recordati and received research support grants from Medtronic. CG is a company consultant for Astellas, GSK, Bayer, STEBA, MSD; received speaker honorarium from Astellas, Pfizer, Recordati, Bayer, IPSEN, Janssen and Amgen; received research grants from Recordati and participated in clinical trials by Astellas, NeoTract and MediTate. M. Gacci has received fellowship and travel grants from Lilly, Bayer, Pfizer, Ibsa, GSK, Astellas, Pierre Fabre, Konpharma, Recordati; has received speaker honorarium from GSK, Lilly, Recordati, Pierre Fabre, Ferring, Berlin-Chemie Menarini, Astellas, Teleflex Medical S.R.L. and participated in clinical trials by Lilly, Ibsa, Astellas, Institut de Recherche de Pierre Fabre. TH is a company consultant for Karl Storz SE & Co. KG Ass. CM participated in clinical trials for Ferring Pharmaceuticals and GlaxoSmithKline; received company speaker honorarium from Astellas and Ferring and received fellowship and travel grants from Astellas, Jansen and Olympus. MR is a company consultant for Boston Scientific, Lilly, Novartis, Astellas, Sanofi, Procept Biorobotics; has received speaker honorarium from Schwabe Pharma and fellowship and travel grants from the Swiss National Science Foundation, Pfizer, Abbvie, GSK and Amgen. MS is a company consultant for ISSECAM IVZW and a share holder in GlaxiSmithKline, Astra Zeneca and Pfizer. I. Kyriazis received Company speaker honorarium from Avatera Medical. SM received company speaker honorarium from Medtronic Ltd.